Advertisement

Topics

Gainor Highlights Future of Immunotherapy in Stage III Lung Cancer Treatment

06:00 EDT 14 Jul 2019 | OncLive

Justin F. Gainor, MD, highlights the evolving paradigm for the use of immunotherapy in the treatment of patients with unresectable locally advanced non–small cell lung cancer.

Original Article: Gainor Highlights Future of Immunotherapy in Stage III Lung Cancer Treatment

NEXT ARTICLE

More From BioPortfolio on "Gainor Highlights Future of Immunotherapy in Stage III Lung Cancer Treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...